IL-27 promotes cardiac fibroblast activation and aggravates cardiac remodeling post myocardial infarction

Xiaoxue Ma,Qingshu Meng,Shiyu Gong,Shanshan Shi,Xiaoting Liang,Fang Lin,Li Gong,Xuan Liu,Yinzhen Li,Mimi Li,Lu Wei,Wei Han,Leng Gao,Zhongmin Liu,Xiaohui Zhou

DOI: https://doi.org/10.1016/j.heliyon.2023.e17099

IF: 3.776

2023-06-18

Heliyon

Abstract:Excessive and chronic inflammation post myocardial infarction (MI) causes cardiac fibrosis and progressive ventricular remodeling, which leads to heart failure. We previously found high levels of IL-27 in the heart and serum until day 14 in murine cardiac ischemia‒reperfusion injury models. However, whether IL-27 is involved in chronic inflammation-mediated ventricular remodeling remains unclear. In the present study, we found that MI triggered high IL-27 expression in murine cardiac macrophages. The increased expression of IL-27 in serum is correlated with cardiac dysfunction and aggravated fibrosis after MI. Furthermore, the addition of IL-27 significantly activated the JAK/STAT signaling pathway in cardiac fibroblasts (CFs). Meanwhile, IL-27 treatment promoted the proliferation, migration and extracellular matrix (ECM) production of CFs induced by angiotensin II (Ang II). Collectively, high levels of IL-27 mainly produced by cardiac macrophages post MI contribute to the activation of CFs and aggravate cardiac fibrosis.